These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 26851353)
1. Daidzein-loaded nanostructured lipid carriers-PLGA nanofibers for transdermal delivery. Song J; Fan X; Shen Q Int J Pharm; 2016 Mar; 501(1-2):245-52. PubMed ID: 26851353 [TBL] [Abstract][Full Text] [Related]
2. Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery. Fan X; Chen J; Shen Q Int J Pharm; 2013 Dec; 458(2):296-304. PubMed ID: 24177313 [TBL] [Abstract][Full Text] [Related]
3. The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability. Ma Y; Zhao X; Li J; Shen Q Int J Nanomedicine; 2012; 7():559-70. PubMed ID: 22346351 [TBL] [Abstract][Full Text] [Related]
4. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption. Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104 [TBL] [Abstract][Full Text] [Related]
5. Nanostructured lipid carriers for the topical delivery of tretinoin. Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827 [TBL] [Abstract][Full Text] [Related]
6. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s). Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192 [TBL] [Abstract][Full Text] [Related]
7. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers. Wang W; Chen L; Huang X; Shao A AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090 [TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery. Noor NM; Sheikh K; Somavarapu S; Taylor KMG Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472 [TBL] [Abstract][Full Text] [Related]
9. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations. Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610 [TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation. Yue Y; Zhao D; Yin Q Biomed Pharmacother; 2018 Feb; 98():813-820. PubMed ID: 29571251 [TBL] [Abstract][Full Text] [Related]
11. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration. Song A; Zhang X; Li Y; Mao X; Han F Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734 [TBL] [Abstract][Full Text] [Related]
12. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema. Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556 [No Abstract] [Full Text] [Related]
13. Nanostructured lipid carriers for percutaneous administration of alkaloids isolated from Aconitum sinomontanum. Guo T; Zhang Y; Zhao J; Zhu C; Feng N J Nanobiotechnology; 2015 Jul; 13():47. PubMed ID: 26156035 [TBL] [Abstract][Full Text] [Related]
14. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery. Kawadkar J; Pathak A; Kishore R; Chauhan MK Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934 [TBL] [Abstract][Full Text] [Related]
15. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers. Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970 [TBL] [Abstract][Full Text] [Related]
16. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy. Wang Y; Wang S; Shi P Drug Deliv; 2016 Nov; 23(9):3193-3199. PubMed ID: 27045388 [TBL] [Abstract][Full Text] [Related]
18. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis. Gu Y; Tang X; Yang M; Yang D; Liu J Int J Pharm; 2019 Jan; 554():235-244. PubMed ID: 30423415 [TBL] [Abstract][Full Text] [Related]
19. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies. Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401 [TBL] [Abstract][Full Text] [Related]
20. Nanostructured Lipid Carriers: A New Paradigm in Topical Delivery for Dermal and Transdermal Applications. Sharma G; Thakur K; Raza K; Singh B; Katare OP Crit Rev Ther Drug Carrier Syst; 2017; 34(4):355-386. PubMed ID: 29199589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]